Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

NCT07218211 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

HIV Prevention
HIV Pre-exposure Prophylaxis
HIV Prevention Program
HIV Prevention and Care
HIV Pre-exposure Prophylaxis Use

Interventions

DRUG: Lenacapavir long-acting

Sponsor

Duke University

Collaborators

[object Object]